![All lanes : Anti-EPM2AIP1 antibody [2A2] (ab119303) at 1/2000 dilutionLane 1 : HEK293T cell lysate transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cell lysate transfected with pCMV6-ENTRY EPM2AIP1 cDNALysates/proteins at 5 µg per lane.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_2/14499_EPM2AIP1-Primary-antibodies-ab119303-1.jpg)
All lanes : Anti-EPM2AIP1 antibody [2A2] (ab119303) at 1/2000 dilutionLane 1 : HEK293T cell lysate transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cell lysate transfected with pCMV6-ENTRY EPM2AIP1 cDNALysates/proteins at 5 µg per lane.

ab119303 at 1/150 dilution staining EPM2AIP1 in Paraffin-embedded Human Liver carcinoma tissue by Immunohistochemistry.

ab119303 at 1/150 dilution staining EPM2AIP1 in Paraffin-embedded Human Ovary adenocarcinoma tissue by Immunohistochemistry.

ab119303 at 1/150 dilution staining EPM2AIP1 in Paraffin-embedded Human endometrium tissue by Immunohistochemistry.

ab119303 at 1/150 dilution staining EPM2AIP1 in Paraffin-embedded Human Endometrium adenocarcinoma tissue by Immunohistochemistry.

ab119303 at 1/150 dilution staining EPM2AIP1 in Paraffin-embedded Human Prostate carcinoma tissue by Immunohistochemistry.

ab119303 at 1/150 dilution staining EPM2AIP1 in Paraffin-embedded Human bladder carcinoma tissue by Immunohistochemistry.

ab119303 at 1/150 dilution staining EPM2AIP1 in Paraffin-embedded Human Lymphoma tissue by Immunohistochemistry.

ab119303 at 1/100 dilution staining EPM2AIP1 in HeLa cells by Flow cytometry (Red) compared to a nonspecific negative control antibody (Blue).

ab119303 at 1/100 dilution staining EPM2AIP1 in Jurkat cells by Flow cytometry (Red) compared to a nonspecific negative control antibody (Blue).